Head of Research, IPOs & Placements, Aequitas Research

Sumeet Singh

Head of Research, IPOs & Placements

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Private Capital Markets

Aster DM Quality Care / Private Capital Markets

<p>Aster DM Healthcare plans to raise up to US$300m through a sale of primary and secondary shares in India. The bulk of the company's operations are in the GCC, with less than 15% of revenue derived from India.</p><p>While the revenue and EBITDA growth has been impressive, the lack of details on the underlying operations of the hospitals, combined with the lack of clarity between organic and inorganic growth makes us wary. </p>

Aster DM Healthcare plans to raise up to US$300m through a sale of primary and secondary shares in India. The bulk of the company's operations are in the GCC, with less than 15% of revenue derived from India.While the revenue and EBITDA growth has been impressive, the lack of details on the underlying operations of the hospitals, combined with the lack of clarity between organic and inorganic growth makes us wary. 

Aster DM Healthcare Pre-IPO Review - Not Enough Information to Make an Investment Case

Market & Forensics Analyst, Beat the Street

Nimish Maheshwari

Market & Forensics Analyst

Beat the Street

Beat The Street was founded by Nimish Maheshwari and Sudarshan Bhandari, both of whom are Chartered Accountants by Profession, known for their expert analysis in the fields of Business, Sectoral analysis, and Corporate governance.

With a strong social media presence of 45,000+ Subscribers across various platforms, they are considered trusted voices in the industry. Their insights and analysis have been featured in some of India’s most prominent publications, including the Economic Times, Dalal Street Investment Journal, The Morning Context, and The Ken.

Their analysis on Bankrupt & Insolvent companies has been instrumental in saving investors from significant losses. They have a keen eye for identifying red flags and has identified exclusive redflags earlier in Vedanta, Nykaa, Dhani Services, Adani and many more.

Read Business Not Stock Prices

Event-Driven

<ul>
<li>
<a href="https://www.smartkarma.com/entities/aster-dm-healthcare-ltd" target="_blank" data-smartkarma-citation="entities:23662:1" rel="noopener">Aster DM Healthcare Ltd (ASTERDM IN)</a> and Quality Care India are merging to form India's third-largest hospital chain with over 10,150 beds. </li>
<li>This merger combines two major players, generating significant scale, diversification, and financial strength. The merged entity will benefit from  synergies and plans to expand to over 13,000 beds by FY27.</li>
<li>The merged entity is expected to be EPS accretive and expected to increase EBITDA by 10-15% through synergies</li>
</ul>



Aster DM Healthcare Ltd (ASTERDM IN) and Quality Care India are merging to form India's third-largest hospital chain with over 10,150 beds. 
This merger combines two major players, generating significant scale, diversification, and financial strength. The merged entity will benefit from  synergies and plans to expand to over 13,000 beds by FY27.
The merged entity is expected to be EPS accretive and expected to increase EBITDA by 10-15% through synergies


Aster DM and Quality Care India: A Deep Dive into the Merger

United Arab Emirates

Aster DM Quality Care is an India-based integrated healthcare provider, offering multi-specialty healthcare services through a network of hospitals, clinics, pharmacies, and diagnostic centers across several Indian states. The company focuses on providing primary, secondary, tertiary, and quaternary care, with specialized centers of excellence in various medical fields. It was founded in 1987 as a single doctor clinic in Dubai, with India operations commencing in 2001, and is headquartered in Bengaluru, Karnataka, India.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Aster DM Quality Care (ASTERDM IN)

Aster DM Healthcare Pre-IPO Review - Not Enough Information to Make an Investment Case

Aster DM Healthcare plans to raise up to US$300m through a sale of primary and secondary shares in India. The bulk of the company's operations are...

Sumeet Singh

Aster DM and Quality Care India: A Deep Dive into the Merger

CCI approved the proposed merger of Quality Care India Limited (QCIL) into Aster DM Healthcare Limited (Aster). Post which Aster will be renamed as...

Nimish Maheshwari

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)